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Abstract
 
Amino acid residues 111–129 represent an immunodominant epitope of myelin basic protein
(MBP) in humans with human leukocyte antigen (HLA)-DRB1
 
*
 
0401 allele(s). The MBP 111–
129–specific T cell clone MS2-3C8 was repeatedly isolated from a patient with multiple sclero-
sis (MS), suggesting an involvement of MS2-3C8 T cells in the pathogenesis. To address the
pathogenic potential of the MS2-3C8 T cell clone, we generated transgenic (Tg) mice express-
ing its T cell receptor and restriction element, HLA-DRB1
 
*
 
0401, to examine the pathogenic
characteristics of MS2-3C8 Tg T cells by adoptive transfer into HLA-DRB1
 
*
 
0401 Tg mice. In
addition to the ascending paralysis typical of experimental autoimmune encephalomyelitis,
mice displayed dysphagia due to restriction in jaw and tongue movements and abnormal gait.
In accordance with the clinical phenotype, infiltrates of MS2-3C8 Tg T cells and inflammatory
lesions were predominantly located in the brainstem and the cranial nerve roots in addition to
the spinal cord and spinal nerve roots. Together, these data suggest a pathogenic role of MBP-
specific T cells in inflammatory demyelination within the brainstem and cranial nerve roots
during the progression of MS. This notion may help to explain the clinical and pathological
heterogeneity of MS.
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Introduction
 
Multiple sclerosis (MS) is a chronic inflammatory demyeli-
nating disorder of the central nervous system (CNS). The
severity of clinical symptoms, the extent of demyelination,
and the location of lesions can vary considerably, suggesting
a high degree of heterogeneity in MS pathogenesis (1). Al-
though the etiology of MS is unknown, the study of exper-
imental autoimmune encephalomyelitis (EAE), an animal
model of MS, and the immunological assessments of MS
patients support the concept that MS is an autoimmune
disease mediated by autoreactive CD4
 
 
 
 T cells with speci-
ficity for myelin antigens (2, 3).
MS has been shown to be a polygenic disease with a
strong genetic link to the human leukocyte antigen (HLA)
complex (4–7). HLA-DR2 is the allele most often associ-
ated with MS in Caucasians (8), especially in the relapsing/
remitting type of MS (9, 10). HLA-DR4 genes have been
found primarily associated with the chronic progressive
type of MS and have been found at higher prevalence in
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MS patients from various ethnic groups, particularly from
the Mediterranean area (11–13). Hence, it appears that cer-
tain HLA-DR molecules, besides conferring disease suscep-
tibility, may also affect phenotypic characteristics in MS in-
cluding disease course. This is consistent with findings in
EAE, where lesion distribution and disease course, i.e.,
chronic relapsing versus acute, vary with MHC class II
background and the antigen used for disease induction (2).
Thus, both the target myelin antigen for autoreactive T cells
and the MHC/HLA class II context are important determi-
nants for disease expression. Immunodominant epitopes of
suspect autoantigens are largely determined by the HLA-
DR allotypes expressed by the patient: whereas myelin basic
protein (MBP) 83–99 is an immunodominant epitope in
DRB1
 
*
 
1501- and DRB5
 
*
 
0101-positive individuals (14,
15), MBP 111–129 is immunodominant in the context of
HLA-DRB1
 
*
 
0401, the most common HLA-DR4 allele
(16). Interestingly, whereas MBP 83–99 is encephalitogenic
in several EAE-susceptible mouse and rat strains (17), MBP
111–129 is a less common encephalitogen (18–20).
To assess the encephalitogenic potential of MBP
111–129–specific T cells, we selected T cell clone (TCC)
MS2-3C8, which had been isolated from the peripheral
blood of a patient with relapsing/remitting MS (16).
MBP-specific T cell lines were established from peripheral
blood obtained from the patient at two time points 25 mo
apart (Fig. 1). The vast majority of MBP-responsive cul-
tures at each time point (92 and 80%, respectively) recog-
nized single epitopes within MBP 111–129 in the context
of HLA-DRB1
 
*
 
0401 and were found to be clonal T cell
populations by TCR sequence analysis. Cloned TCR se-
quences identical to MS2-3C8 were overrepresented and
detected at both time points. The repeated isolation of
these clonal T cells indicated a persistent expansion and
suggested relevance to the disease process. Previously, hu-
manized TCR transgenic (Tg) mouse models were found
suitable to assess the pathogenic potential of human TCR
(21); thus, we chose the MS2-3C8 TCR for the genera-
tion of humanized TCR Tg mice to examine whether
human MBP 111–129–specific and DRB1
 
*
 
0401-restricted
T cells have encephalitogenic potential. To explore the
pathogenic potential of MS2-3C8 T cells in a murine
model, one must consider that murine MBP 111–129 dif-
fers from the human sequence by a conservative Arg to
Lys substitution in position 122, which might affect T cell
recognition. Indeed, whereas MS2-3C8 TCC responded
to both human and murine peptides, we found that some
MBP 111–129–specific human TCCs did not cross-react
with murine MBP 111–129 and therein serve as experi-
mental controls.
 
Materials and Methods
 
Animals.
 
HLA-DRB1
 
*
 
0401 Tg mice lacking the endoge-
nous MHC class II, IA, and IE were purchased from Taconic
Farms or bred in our facility. Rag 1
 
 
 
/
 
 
 
 Tg mice were purchased
from Jackson Laboratory. Mice were housed in specific patho-
gen-free facilities at the National Institutes of Health.
 
Generation of Human TCR–HLA-DRB1
 
*
 
0401–IA
 
 
 
/
 
 
 
 Tg
Mice.
 
Rearranged MS2-3C8 TCR V
 
 
 
 (AV4S1AJ32) and V
 
 
 
(BV2S1BJ1S6) chains were amplified from genomic DNA using
primer pairs located in introns upstream and downstream of the
V-(D)-J regions. The rearranged V
 
 
 
 and V
 
 
 
 segments were sub-
cloned into a pair of cassette vectors, pT
 
 
 
 and pT
 
 
 
, respectively
(22). The chimeric gene constructs were microinjected into
Figure 1. Relationship between the clinical
course of patient with MS and the isolation
of MS2-3C8 TCR. (A) The clinical course
of the MS patient from whom MS2-3C8 T
cell clone was isolated. The onset of clinical
symptoms that led to the diagnosis of MS
preceded by 16 mo the initial visit at the
Neuroimmunology Branch, National Insti-
tutes of Health (indicated as Start on panel
A, horizontal axis). The subsequent follow-
up time points are expressed in months from
the start. Clinical exacerbations that required
i.v. steroid treatment are indicated by black
bars. The text boxes with black arrows in-
dicate two clinical episodes experienced by
the patient involving cranial nerves, including
tongue motor or sensory function, saliva-
tory function, and taste. Limiting dilution
assays (LDA) were performed from PBMC
obtained at two time points (I and II) as in-
dicated by the white arrows. (B) Persistent
presence of MS2-3C8 T cell clone in the MS
patient shown in A. T cell clone MS2-3C8
was isolated from LDA I. TCR sequences
identical to MS2-3C8 were obtained from
T cell clones isolated from LDA II, showing
the persistence of the MS2-3C8 TCC for at
least 26 mo of follow-up. 
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C57BL/6 fertilized eggs at SAIC. Using the same approach, chi-
meric TCR Tg mice were also generated from the healthy do-
nor-derived human MBP 111–129–specific HLA-DRB1
 
*
 
0401-
restricted HD4-1C2 T cell clone (16) that is unresponsive to
murine MBP 111–129.
 
FACS
 
®
 
 Analysis.
 
Anti–HLA-DR (FITC) and anti–human
TCR V
 
 
 
 2 (PE/FITC/biotinylated) were purchased from Coulter-
Immunotech. Other fluorescently labeled antibodies were pur-
chased from BD Biosciences. FACS
 
® 
 
analysis was performed on a
FACSCalibur using CellQuest software (Becton Dickinson).
 
Tissue Culture.
 
Purified human and murine MBP 111–129
(Hu-MBP 111–129, LSRFSWGAEGQRPGFGYGG; Mu-MBP
111–129, LSRFSWGAEGQKPGFGYGG) synthetic peptides
were purchased from the Stanford Pan Facility. Murine IL-12
and IL-2 were purchased from Peprotech. CD4
 
 
 
 or CD8
 
 
 
splenic T cells (
 
 
 
95% pure by FACS
 
®
 
 analysis) obtained by posi-
tive selection using anti-CD4– or anti-CD8–coated microbeads
(Miltenyi Biotec) were cultured with human and murine MBP
111–129. 4 
 
 
 
 10
 
4
 
 Tg T cells and 4 
 
 
 
 10
 
5
 
 irradiated (3,000 rad)
spleen cells from HLA-DRB1
 
*
 
0401–IA
 
 
 
/
 
 
 
 Tg mice were incu-
bated at 37
 
 
 
C for 72 h and 1 
 
 
 
Ci [
 
3
 
H]thymidine (Dupont) was
added to each well for the last 12 h of culture. Quantitation of se-
creted cytokines was measured by Duoset Murine ELISA kits
(R&D Systems). The proliferation of human T cell clones were
analyzed as described previously (16).
 
Induction of EAE.
 
CD4
 
 
 
 MS2-3C8 and HD4-1C2 Tg Th1
cells were established by cultivation of Tg spleen cells with Hu-
MBP 111–129 (10 
 
 
 
g/ml) in the presence of IL-12 (3 ng/ml) as
described previously (23). Once cells had rested from the antigen
and IL-12–driven Th1 differentiation (typically day 10), cells
were again stimulated with MBP 111–129 at 10 
 
 
 
g/ml without
IL-12. After 3–4 d, 10–20 million Tg T cells were transferred
into irradiated (350 rad) HLA-DRB1
 
*
 
0401–IA
 
 
 
/
 
 
 
 Tg mice (10–
12 wk old). Pertussis toxin (200 ng) was administered i.v. on days
0 and 2. Mice were weighed daily and assigned clinical scores of
ascending EAE paralysis as follows: 0, no symptoms; 1, limp tail;
2, hindlimb weakness; 3, hindlimb paralysis; 4, hindlimb and
forelimb paralysis.
 
Histological Examination.
 
Deeply anesthetized mice were per-
fused with 30 ml of cold PBS followed by 30 ml of PBS contain-
ing 4% paraformaldehyde. The brain and spinal column were
carefully removed and post-fixed in 4% formaldehyde for up to
7 d, at which time the spinal cord was removed from the spinal col-
umn and embedded in paraffin for sectioning in selected animals.
The cranium and vertebral column tissues were trimmed with the
brain and spinal cord in place after the fixed cranial and vertebral
tissues were routinely decalcified. The select tissue blocks contain-
ing cranial tissues were serially sectioned with sections taken at 25-
 
 
 
m intervals for staining. Alternatively, PBS-perfused tissues were
cut and prepared for frozen sections. Immunohistochemical analy-
sis of the frozen sections was performed by BD Biosciences.
 
Results
 
Development of Humanized Tg T Cells in MS2-3C8 TCR–
HLA-DRB1
 
*
 
0401–IA
 
 
 
/
 
 
 
 Tg Mice.
 
MS2-3C8 chimeric
TCR 
 
 
 
 and 
 
 
 
 gene constructs containing the human TCR
V
 
 
 
4.1-J31/V
 
 
 
2.1-D-J1.6 and mouse TCR constant re-
gions were microinjected into C57BL/6 fertilized eggs,
and the TCR Tg offspring were crossed with HLA-
DRB1
 
*
 
0401–IA
 
 
 
/
 
 
 
 Tg mice, which were deficient in the
expression of endogenous mouse MHC class II (22). Since
neither a MS2-3C8 TCR-specific clonotypic antibody nor
a Tg human TCR V
 
 
 
 4 mAb were available, a human
TCR V
 
 
 
2 mAb was used for the analysis of Tg TCR V
 
 
 
expression. The Tg TCRV
 
 
 
2 chain was equally expressed
on both CD4
 
 
 
 and CD8
 
 
 
 T cell subsets in the Tg mice on
the C57BL/6 background (not depicted). However, the
V
 
 
 
2
 
 
 
 Tg T cells skewed to the CD4
 
 
 
 T cell subset and
V
 
 
 
2
 
 
 
 Tg T cells represented 
 
 
 
80% of CD4
 
 
 
 CD3
 
 
 
 T
cells when these Tg mice were crossed with HLA-
DRB1
 
*
 
0401–IA
 
 
 
/
 
 
 
 Tg mice (Fig. 2, A and B), suggesting
that HLA-DRB1
 
*
 
0401 mediates positive thymic selection
of HLA-DRB1
 
*
 
0401–restricted Tg T cells. This was con-
firmed in Tg mice lacking the expression of both MHC
class II molecules, HLA-DRB1
 
*
 
0401 and mouse MHC
class II. In these Tg mice, CD4
 
 
 
 V
 
 
 
2
 
 
 
 Tg T cells did not
develop in the thymus, whereas CD8
 
 
 
 V
 
 
 
2
 
 
 
 Tg T cells
were still positively selected (not depicted). To eliminate
the influence of endogenous TCR on thymic selection, we
crossed the MS2-3C8 TCR–HLA-DRB1
 
*
 
0401–IA
 
 
 
/
 
 
 
 Tg
mice with Rag-1 /  mice. We observed a large reduction
in Tg T cells in the thymus and spleen of MS2-3C8 TCR–
HLA-DRB1*0401–IA / –Rag-1 /  Tg mice. CD8  Tg
T cells could not be detected in the spleen. In contrast, a
small number of CD4  Tg T cells could still develop but
only when HLA-DRB1*0401 was expressed (Fig. 2 C).
Splenic V 2-expressing peripheral CD4  T cells were of
naïve phenotype with low levels of CD44, high levels of L
selectin and CD45RB (Fig. 2 D), and showed a predomi-
nantly Th0 helper profile with negligible amounts of
IFN-  or IL-10 and low to moderate amounts of the cyto-
kines IL-4, TNF- , and IL-2 (Fig. 2 E). In contrast, CD8 
T cells produced large quantities of IFN-  with low to
moderate production of IL-10 and IL-4.
Prior to determining the capacity of these CD4  Tg T
cells to induce disease, we assessed their specificity. The
original CD4  human T cell clone, MS2-3C8, proliferated
in response to both human and mouse MBP 111–129 with
consistently higher sensitivity to the human epitope (Fig.
3). This dual specificity and the pattern of increased relative
sensitivities to the human epitope (the EC50 was typically
one half log greater for human MBP 111–129) were pre-
served in the CD4  Tg T cells. As a negative control, we
generated HD4-1C2 Tg mice in which Tg T cells re-
sponded only to human MBP 111–129 in the context of
HLA-DRB1*0401. The murine MBP 111–129 epitope
failed to elicit any proliferative response at all (Fig. 3).
MS2-3C8 CD4  Tg T Cells Induce Atypical EAE Signs
Besides Typical Ascending Paralysis. We isolated CD4 
MS2-3C8 TCR Tg T cells from spleens and examined
their potential to induce EAE in adoptive transfer experi-
ments. Since EAE is a prototypic Th1-mediated autoim-
mune disease, we generated Th1 T cells from the spleen
cells of two different Tg founder lines, B6 and G2 (Table
I), and transferred them into irradiated HLA-DRB1*0401–
IA /  Tg mice. The MS2-3C8 (B6) Tg T cell line exhib-
ited signs of typical ascending paralysis, correlating with
hindlimb weakness and tail limpness averaging a grade 2 onPathogenic Potential of DRB1*0401-restricted MBP 111–129 T Cells 226
Figure 2. Development of MS2-3C8 TCR Tg T cells in the thymus and spleen. (A) Thymic expression of the Tg TCR. Thymocytes from MS2-3C8
TCR and non–MS2-3C8 TCR Tg mice (7 wk old) were stained with anti-CD4 mAb, anti-CD8 mAb, and TCR V 2 mAb. Genotypes of the Tg mice
are described at the top. Histograms were gated on the CD4 CD8  (CD4 SP), CD4 CD8  (CD8 SP), CD4 CD8  (DP), and CD4 CD8 (DN) T
cells and analyzed for V 2 expression (filled histograms) and isotype controls (open histograms). Thymocyte counts: non-TCR Tg mouse, 2.7   108;
TCR Tg mouse, 3.6   107. (B) Splenic expression of the Tg TCR. The spleen cells from the Tg mice analyzed in A were stained by anti-CD3 mAb and
anti-TCRV 2 mAb (top), anti-CD4 mAb, anti-CD3 mAb, and anti-V 2 mAb (middle), and anti-CD8 mAb, anti-CD3 mAb, and anti-V 2 mAb (bot-
tom). Histograms were gated on the CD4 CD3  and CD8 CD3  and analyzed for V 2 expression (filled histograms) compared with isotype controlsQuandt et al. 227
the EAE clinical assessment scale in irradiated HLA-
DRB1*0401–IA /  Tg mice (Fig. 4 and Table II). In addi-
tion to the typical ascending paralysis, several EAE mice
spun briskly when hung by their tails and later developed
circulating movement or head-tilt (Table II). Of further in-
terest, several mice exhibited difficulty swallowing and lin-
gual paralysis due to restricted jaw and/or tongue move-
ments (Table II). Swallowing difficulties were typically
observed by days 14–18 and subsequently progressed in
several mice to lingual paralysis. By days 16–20, mice had
lost  20% of their body weight after the onset of typical
ascending EAE symptoms and eventually appeared mori-
bund (Fig. 4). According to the Animal Care and Use
Committee guidelines for maximal allowed weight loss,
these mice had to be killed after unsuccessful efforts to ga-
vage mice and slow weight loss. Although typically ascend-
ing EAE symptoms had usually not progressed beyond
grade 2 by the time of sacrifice, the complications of the
lingual paralysis did not allow us to follow mice for evi-
dence of neurological or CNS disease worsening. To ex-
clude the possibility that these clinical characteristics are
caused by silencing or induction of genes upon transgene
integration, we examined CD4  MS2-3C8 Tg T cells
from another Tg founder line, MS2-3C8 (G2). Similar
EAE symptoms were observed with CD4  MS2-3C8 (G2)
TCR Tg T cells (Fig. 4 and Table II); however, circulating
movement or head-tilt were less frequently induced than
with CD4  MS2-3C8 (B6) Tg T cells. To confirm that
this EAE phenotype is caused by the specificity of the
MS2-3C8 Tg TCR, we transferred CD4  MS2-3C8 Tg
Th1 cells established from MS2-3C8 (B6) TCR–HLA-
DRB1*0401–IA / –Rag-1 /  Tg mice into irradiated
HLA-DRB1*0401–IA /  Tg mice. We observed earlier
disease onset with ascending paralysis followed by dys-
phagia attributable to lingual paralysis (Fig. 4 and Table II),
supporting that the MS2-3C8 TCR specificity is involved
in this phenotypic presentation. Control experiments with
CD4  HD4-1C2 Tg T cells, which do not respond to mu-
rine MBP 111–129, failed to induce any EAE signs (Fig. 4
and Table II).
Inflammatory Lesions Are Observed in the Brainstem and Cra-
nial Nerves and in the Spinal Cord and Spinal Nerve Roots.
Histological analysis demonstrated moderate to severe in-
filtration of inflammatory cells into the meninges and pa-
renchyma of the spinal cord and brainstem (Fig. 5, A and
D, and Table III). Although the predominant cell infiltrate
was mononuclear cells consisting of CD4  lymphocytes
and macrophages, in some areas polymorphonuclear
leukocyte (Ly-6G ) infiltration was prominent (Fig. 6).
CD8  lymphocytes (Fig. 6) and B cells (not depicted) were
Figure 2 (continued)
(open histograms). The percentage of cells in each quadrant/gate are indi-
cated. Splenocyte counts: non-TCR Tg mouse, 1.5   108; TCR Tg
mouse, 6.7   107. (C) Thymic selection and splenic expression of MS2-
3C8 (B6) TCR Tg T cells in Tg mice on the Rag-1 /  background.
Numbers indicate the percentage of cells in each quadrant. The cell
numbers are as follows: MS2-3C8 TCR–HLA-DRB1*0401–IA / –
Rag-1 /  Tg mouse, thymocytes, 3.1   107 and splenocytes, 2.6   106;
MS2-3C8 TCR–HLA-DRB1*0401 / –IA / –Rag-1 /  Tg mouse,
thymocytes 3.3   107 and splenocytes 2.0   106. (D) Phenotypic charac-
terization of CD4  MS2-3C8 Tg T cells. Expression of phenotypic
markers on naïve splenic T cells isolated from MS2-3C8 TCR–HLA-
DRB1*0401–IA /  Tg mice and MS2-3C8 Tg splenic cells activated in
vitro with human MBP 111–129. Histograms were gated on V 2  CD4 
cells or those stained after 48 h of activation. (E) Cytokines produced by
CD4  or CD8  Tg T cells isolated from MS2-3C8 TCR–HLA-
DRB1*0401–IA /  Tg mice. 48-h supernatants were collected from human
MBP 111–129–stimulated (10  g/ml) cultures of CD4  or CD8  T cells,
as described for the activation marker analysis, and analyzed by ELISA.
Table I. Cytokine Production of Tg T Cell Lines
IFN-  TNF-  IL-10 IL-4
Tg T cell line Mu Hu Mu Hu Mu Hu Mu Hu
MS2-3C8(B6) 26.6 52.6   1.1 4.2   0.1 7.0   0.2 0.1 0.1 0.6 0.8
MS2-3C8(G2) 22.2   1.8 50.8   7.1 2.8   0.1 4.8   0.3 1.0 1.3 1.3 1.8
HD4-1C2 0 156.4   7.2 0 4.8   0.7 0 0.3 0 0.8
Splenic MS2-3C8 and HD4-1C2 Th1 cell lines were confirmed by high IFN-  and TNF-  production after culture with 1  g/ml of human MBP
111–129 (Hu) or murine MBP 111–129 (Mu) for 72 h. The unit of cytokine production is indicated as ng/ml   SD.Pathogenic Potential of DRB1*0401-restricted MBP 111–129 T Cells 228
Figure 3. The antigenic specificity of the original
human TCRs was preserved in the humanized
TCR Tg mice. Shown are the proliferative responses
of the MS2-3C8 and HD4-1C2 human TCCs,
mouse splenic CD4  MS2-3C8 and HD4-1C2
TCR Tg T cell lines (TCL), and splenic CD4 
MS2-3C8 TCR Tg and HD4-1C2 TCR Tg T
cells to human MBP 111–129 ( ) and mouse MBP
111–129 ( ).
Table II. Development of EAE by Adoptive Transfer with Tg Th1 Cell Lines
Ascending paralysisa Dysphagiab Abnormal gaitc
Tg T cells Incidence Severity Onset Incidence Weight loss (%) Onset Incidence Onset
MS2-3C8 (B6) 11/19 1.8   0.8 16   4 10/19 23   6 19   3 10/19 18   3
MS2-3C8 (B6)–Rag-1 /  13/13 2.0   0.8 8   2 8/13 27   4 11   1 0/13 –
MS2-3C8 (G2) 7/9 2.1   0.4 14   6 5/9 21   5 20   5 1/9 25
HD4-1C2 0/9 – – 0/9 – – 0/9 –
The source of the Th1 cell line and the number of mice out of each experiment showing any sign of disease are indicated as well as the mean day of
onset   SD. 10–20 million cells were transferred i.v. after 4 d of in vitro stimulation with human MBP 111–129. Pertussis toxin was administered
i.v. on days 0 and 2. Clinical symptoms were divided into three groups to distinguish aascending paralysis from the atypical symptoms of bdysphagia
with accompanying weight loss ( 20% body weight) and difficulties swallowing or cabnormal gait including spinning, head-tilt and loss of coordi-
nated movement. Ascending paralysis on a scale of 0–4: 0, no symptoms; 1, limp tail; 2, hindlimb weakness; 3, hindlimb paralysis; 4, hindlimb and
forelimb paralysis. Dysphagia described as the percentage of weight loss compared with peak body weight over course   SD. Results were pooled
from two to five independent experiments.
not apparent. The inflammatory infiltrate was com-
monly perivascular, but inflammatory cells were scattered
throughout the affected area (Fig. 5, A and D). In some
animals, demyelination was noted by pallor of myelin and
Luxol Fast blue–positive debris in the tissue and within
macrophages (Fig. 5, A–C). In some areas, severe inflam-
mation was associated with tissue vacuolation and necro-
sis. In many areas, especially in proximity to necrotic ar-
eas, numerous axonal spheroids indicated axonal damage,
and microthrombi were occasionally observed in blood
vessels within inflamed areas (not depicted). Inflammation
affected both cerebellum and cerebral hemispheres less
frequently, however, than the spinal cord and brainstem
(Table III).
Of particular interest was the finding of cellular inflam-
mation within the proximal peripheral nervous systemQuandt et al. 229
Table III. The Location and Severity of Inflammatory Lesions
T cell lines MS2-3C8 (B6) MS2-3C8 (B6)/Rag1    MS2-3C8 (G2)
Ascending
paralysis 0 2 3 2 32 23 2 2 2 2 2
Weight loss (%) 0 22 17 32 15 32 10 25 32 23 22 22 14
CNS
Spinal cord –                
                               
    
    
     
    
    
   
    
Brainstem –          
    
   
                               
    
   
       
Cerebellum – – –   –– ––   –– –  
Cerebrum – – –    ––              
PNS
Spinal root – –    –    –       –            
Sciatic and 
axillary nerves ––   –   –– – –   –   –
Cranial nerves –            
                         
   
   
           
   
Th1 cells from the Tg mice listed were isolated and transferred into irradiated HLA-DRB1*0401–IA /  Tg mice. The EAE score and percentage of
weight loss are listed for 13 animals which were examined histologically. For comparative purposes, a visual grading scheme was assigned to the lesions
in each of the animals examined. The histological score of inflammatory lesions is as follows:  , occasional inflammatory cell cuffing in meninges;
  , mild lesions in a few sections ( 50%);    , mild or moderate lesions in many sections ( 50%);     , severe or moderate changes in a
few sections ( 50%);      , severe or moderate changes in many sections ( 50%). Necrosis and axonal degeneration were observed in most
lesions of grade 4 to 5 (     →      ) severity. Demyelination, as observed in Luxol Fast blue–stained slides, was seen in the spinal cord and
brainstem in 6 of 12 mice examined.
Figure 4. Development of ascending paralysis and weight loss after transferring CD4  Tg Th1 cells into irradiated HLA-DRB1*0401–IA /  Tg mice
(four to five mice for each group). Adoptive transfer of Tg Th1 cells established from MS2-3C8 (G2) Tg and MS2-3C8 (B6) Tg–Rag-1 /  or Tg–Rag-1 / 
mice recognizing murine MBP 111–129 induced disease. HD4-1C2 Tg Th1 cells, nonresponsive to murine MBP 111–129, gave rise to no clinical
symptoms. Mice which lost  20% of their body weight (typically attributed to lingual paralysis or swallowing difficulties observed) were killed per the
Animal Care and Use Committee guidelines.Pathogenic Potential of DRB1*0401-restricted MBP 111–129 T Cells 230
(PNS) and CNS tissues. In some instances, PNS and CNS
involvement coincided (Fig. 5 D), whereas in other in-
stances, the inflammatory process appeared to selectively
involve the PNS (Fig. 5 E) and was most intense in the
nerve root between the spinal cord and ganglion. There
was little evidence for inflammation along the peripheral
nerve beyond the extradural space (Table III). However,
occasional inflammatory infiltration of the peripheral
nerves was seen in a few sections (Table III). In mice that
developed dysphagia, particular attention was given to in-
flammatory lesions in the cranial nerves, particularly the
root entry areas. In these animals, the brains were left in the
Figure 5. Histopathological analysis of
the brain, spinal cord, and cranial nerves of
mice exhibiting symptoms of EAE induced
with MS2-3C8 Tg Th1 cells. (A) A section
of brainstem from an irradiated HLA-
DRB1*0401–IA /  Tg mouse with EAE
(grade 2) induced by MS2-3C8 (B6) Tg T
cells. There is a heavy inflammatory infiltrate
around blood vessels (arrowheads) and lying
free in the parenchyma, and in the cochlear
nucleus (bottom right corner). The arrow
points to an area of pallor, seen to better effect
in B. Hematoxylin and eosin,  75. (B) Ad-
jacent section to that depicted in A stained
for myelin. The arrow shows a demyeli-
nated area in the inferior cerebellar peduncle.
The normally myelinated peduncle is seen
above (m). Luxol Fast blue,  75. (C) Mag-
nification of the section depicted in B,
showing active demyelination with Luxol
Fast blue debris (arrows) lying free or within
macrophage cells. Luxol Fast blue,  817.
(D) A section of spinal cord from an animal,
experimentally identical to that depicted in
A. White matter and grey matter are indi-
cated as (w) and (g), respectively. A heavy
infiltrate of chronic inflammatory cells in
seen in the meninges (arrow) and in the
perivascular space of the lateral column
white matter (arrowhead). The bundle of
spinal roots (r) seen on the left side of the
picture also shows a marked inflammatory
infiltrate. Hematoxylin and eosin,  144.
(E) Spinal cord section from an animal with
an experimental paradigm the same as the
animal depicted in D. In this section, the
spinal cord parenchyma shows no evidence
of inflammation. The peripheral nerve bundle
lying in the meninges (r) shows cellular in-
flammatory infiltration, which is also seen in
the meningeal sheath. Of interest is the
junction between central and peripheral
myelin, shown here by the arrowhead. The
central cone of the emerging root is unaf-
fected, whereas the peripheral nerve com-
ponent is infiltrated. Hematoxylin and eosin,
 213. (F) A cross section of cranial contents
from an irradiated HLA-DRB1*0401–IA / 
Tg mouse with EAE (grade 2) induced by
MS2-3C8 (G2) Tg T cells. Cranial tissues
from this animal were decalcified, and serial
sections were stained with hematoxylin and
eosin ( 12). There is a marked inflammatory
cell infiltrate in the cranial nerve root entry/
exit zones of brainstem (arrow) and cranial
nerve roots (arrowhead). (G) High magnifi-
cation of the area marked by an arrowhead in F. There is a marked inflammatory cell infiltration of both the cranial nerve roots and the cranial nerve
ganglia. The roots and ganglia lie between two bony spicules. Hematoxylin and eosin,  200. (H) A cross section of cranial contents from an animal, ex-
perimentally identical to that depicted in F. Tissue section contains the brain, a branch of the trigeminal cranial nerve and the tympanic cavity of the
middle ear. There is a marked inflammatory cell infiltration of trigeminal nerve (arrows). Hematoxylin and eosin,  12. (I) High magnification of the area
marked by the arrow in H showing marked leukocytic infiltration of the trigeminal nerve ganglia (arrowhead) and the peripheral nerve bundle (arrow).
Hematoxylin and eosin,  200.Quandt et al. 231
cranium, and subsequent to decalcification serial sections
were made to evaluate the extent of inflammation along
the path of the cranial nerve roots. Inflammation was ob-
served in the vestibulo-cochlear (Fig. 5 F) and the trigemi-
nal nerves (Fig. 5 H). There were severe infiltrates in the
ganglia and roots of these cranial nerves (Fig. 5, G and I)
and entry/exit zones of brainstem (Fig. 5 F). The inflam-
mation was greatly decreased in more distal sections of the
cranial nerves (not depicted). Immunohistochemical analy-
sis revealed infiltrates of V 2  Tg T cells in the lesions of
the cranial nerve roots and the brainstem (Fig. 6). These
histological analyses suggest the involvement of MS2-3C8
Tg T cells in the development of neurological damage of
the brainstem and cranial nerves with subsequent clinical
signs such as difficulty of tongue and jaw movements in an-
imals showing atypical EAE.
Discussion
Classical selection theories suggest that antigen expres-
sion in the thymus should lead to central deletion of T cells
encountering their cognate antigen. However, there are
several possible explanations for the survival of MS2-3C8
Tg TCR T cells. Golli-MBP, the isoform of MBP ex-
pressed in the thymus, does not contain MBP 111–129,
and therefore deletion would not necessarily be expected
(24, 25). Even if classical MBP were to enter the thymus
from the periphery and be presented by thymic APCs, the
low binding affinity of MBP 111–129 to DRB1*0401 (16)
may allow their escape from deletion. This rationale might
also explain the survival of Tg TCR T cells in other myelin
protein–specific TCR Tg mice, humanized or not (21, 26–
28). Except for MBP 83–99, each of these myelin peptides
is either a poor MHC binder or not expressed in the thy-
mus, e.g., MOG 35–55 and PLP 139–154 (29, 30). How-
ever, we observed a marked reduction in MS2-3C8 Tg T
cells when the mice were crossed to Rag-1 /  mice due to
negative selection or lack of positive selection. Analysis of
thymocyte cellularity and CD5 expression on CD4 CD8 
double positive thymocytes suggested the reduction is
caused by thymic negative selection (unpublished data).
Moreover, Tg T cells that escaped thymic deletion may
have expressed endogenous mouse TCR together with the
Tg  /  TCR heterodimer; thus, dual TCR expression on
the Tg T cells may have led to their survival.
In MS2-3C8 TCR–HLA-DRB1*0401 Tg mice, Tg T
cells were not activated in vivo (Fig. 2 D) and mice did not
develop spontaneous EAE (unpublished data). Since the
MS2-3C8 human TCC is a CD4  T cell, we investigated
the pathogenic characteristics of CD4  Tg T cells. To
eliminate the influence of CD8  and DN Tg T cells on the
induction of EAE, we isolated CD4  Tg T cells from
spleen cells and transferred CD4  Th1 Tg cells into irradi-
ated HLA-DRB1*0401 Tg mice. For comparison with the
MS2-3C8 TCR, we generated HD4-1C2 TCR Tg mice
from a human T cell clone which does not cross-react to
the mouse epitope. We show that MS2-3C8 Tg CD4 
Th1 cells induced EAE, whereas HD4-1C2 Tg CD4  Th1
cells did not, indicating that EAE induction is mediated by
MS2-3C8 TCR recognition of the murine MBP 111–
129–HLA-DRB1*0401 complex. This was confirmed us-
ing MS2-3C8 TCR–Rag-1 /  Tg T cells which lack en-
dogenous mouse TCRs (Fig. 4 and Table II). Since the
CD8  Tg T cells expressed CD28 and produced high
amounts of IFN-  in response to MBP 111–129, we ex-
amined the pathogenic potential of CD8  Tg T cells by
adoptive transfer into irradiated HLA-DRB1*0401–IA / 
Tg mice. We did not observe any signs of EAE in animals
receiving 10–20 million CD8  Tg T cells, nor did the
cotransfer of 10 million CD8  Tg T cells at a 1:1 ratio with
CD4  Tg T cells suppress or worsen passive EAE (unpub-
lished data). Active EAE could not be induced despite nat-
ural processing of MBP 111–129 and the stimulation of Tg
T cells in vivo (unpublished data). Peripheral mechanisms
of tolerance were not apparent as the explanation for inef-
Figure 6. Immunohistochemical analysis of inflammatory infiltrates in
brainstem and cranial nerve root. Frozen sections of brainstem from an
irradiated Tg mouse with EAE (grade 2) induced by MS2-3C8 (B6) Tg T
cells were stained for hematoxylin and eosin, CD4, Mac3, CD8, Ly-6G,
and isotype control mAbs. Cranial nerve root (n) and brainstem (w) were
stained with anti-V 2 and isotype control mAbs.Pathogenic Potential of DRB1*0401-restricted MBP 111–129 T Cells 232
fective active disease induction, since Tg T cells isolated
from the spleen or lymph node proliferated in response to
MBP 111–129, unaffected by addition of IL-2 (not de-
picted). Other mechanisms involved in active EAE sup-
pression are currently under investigation.
MS presents with substantial clinical and pathologic het-
erogeneity (1). Previous data from genetic studies on HLA-
DR associations with MS (4–7) and EAE experiments in
animals with different MHC class II backgrounds and dif-
ferent encephalitogens (2) suggest the clinical phenotype of
MS–EAE is in part caused by the expression of different
HLA-DR–MHC class II alleles and the T cell response to
specific myelin peptides. Since the HLA-DR2 haplotype is
strongly associated with MS, and HLA-DRB1*1501 and
HLA-DRB5*0101 genes are coexpressed in humans carry-
ing the HLA-DR2 allele, HLA-DRB1*1501-restricted
MBP 83–99–specific TCR Tg mice were generated. The
Tg mice developed spontaneous ascending paralysis (21).
Recently, we have developed a HLA-DRB5*0101-
restricted MBP 83–99–specific human TCR Tg mouse
(TL3A6 Tg mice). The TL3A6 Tg Th1 cells induced se-
vere ascending paralysis, although they do not induce lin-
gual paralysis in spite of weight loss (unpublished data). In
accordance with the clinical symptoms, the lesions were
predominantly observed in the spinal cord, and less inflam-
matory cells infiltrated into the cranial nerves (unpublished
data). Therefore, lingual paralysis associated with the in-
flammation of brainstem and cranial nerves was a unique
feature of MS2-3C8 Tg mice.
The patient from whom the MS2-3C8 TCC was de-
rived did not suffer from chronic persisting dysphagia;
however, the patient did present two episodes, one consist-
ing of disturbances in tongue movement impairing swal-
lowing of fluids and speech articulation and a second epi-
sode consisting of tongue numbness and dysgeusia (Fig. 1).
These episodes were comprised between the two time
points at which MS2-3C8 TCRs were isolated. We are
well aware that the relationship between MBP 111–129–
specific T cell responses (or the presence of a specific TCR)
and the manifestation of clinical signs and symptoms should
be interpreted with caution; however, the phenotypic
characteristics of this particular EAE model and the similar-
ities in the patient’s clinical history are intriguing. Interest-
ingly,  30-40% of MS patients develop dysphagia (31–33),
albeit typically late in disease.
Clearly, several factors can contribute to the clinical
manifestations of EAE in any one particular model, perhaps
the two greatest contributors being the genetic background
and the immunizing myelin antigen or the target autoanti-
gen. It has been reported that the antigenic epitope speci-
ficity of myelin antigens influences the phenotype of EAE
and location of the lesions. In Balb/c (IAd, IEd) mice, IAd-
restricted MBP 59–76–specific T cells induce classical EAE
with characteristic inflammation and demyelination of the
CNS (34). In contrast, IEd-restricted MBP 151–168–spe-
cific T cells induce inflammation and demyelination of
preferentially PNS myelin including nerves in the hind leg
and spinal roots. The authors suggested two possibilities to
explain their result. The first is that the distinct inflamma-
tion sites may be attributable to qualitative differences in
MBP isoform composition in the CNS and PNS. The
MBP 151–168 epitope, which is encoded by exons 6 and
7, exists only in the 18.5- and 21-kD MBP isoforms,
whereas the MBP 59–76 epitope exists in all of the 14-,
17-, 18.5-, and 21-kD isoforms. The minimal epitope of
MBP recognized by the MS2-3C8 TCR, MBP 116–123
(16), is encoded by exons 5 and 6. Therefore, similar to the
MBP 151–168 epitope recognition described above, only
the 18.5- and 21-kD isoforms are recognized by MS2-3C8
Tg T cells. Although the quantitative distribution of these
isoforms is unknown at the present, the unique EAE phe-
notype inducible by MS2-3C8 Tg T cells may be caused
by the distinct distribution of MBP isoforms in the CNS
and PNS. Second, the authors suggested that high versus
low affinity interactions in the complex of MBP–IA or –IE
molecules may generate distinct downstream signaling
events after TCR engagement. Interestingly, MBP 59–76
strongly binds to IAd molecules, whereas MBP 151–168
weakly binds to IEd molecules. Such differences are likely
to affect the expression of adhesion and costimulatory mol-
ecules involved in transmigration through perivascular en-
dothelial cells of either the blood-brain or blood-nerve
barrier, and thus influence factors key to T cell encephali-
togenicity. This hypothesis was supported by EAE experi-
ments in CH3 congenic mice where immunization of H2q
congenic C3H mice with PLP 103–116 induces typical as-
cending EAE. In contrast, immunization of H2p congenic
C3H mice with the same antigen induces atypical EAE,
ataxia, and imbalance without any symptoms of ascending
paralysis (35). The binding affinity of PLP 103–116 to IAp
was lower than that to IAq, suggesting that antigen binding
affinity of myelin antigens to MHC class II molecules
could influence the phenotype of EAE. Moreover, signals
through TCR and costimulatory molecules could lead to
the expression of adhesion molecules and chemokine pro-
duction that are involved in the infiltration of pathogenic
T cells. EAE experiments that used CD28-deficient mice
supported this hypothesis. When the CD28-deficient mice
were immunized with MOG 35–55, inflammatory cells
predominantly infiltrated into the leptomeninges of the
brain although immunization of wild-type mice with the same
antigen induced typical ascending paralysis with the infil-
trates in the parenchyma of the CNS (36). Similarly, the
poor binding of MBP 111–129 to HLA-DRB1*0401 mol-
ecules and the signaling events subsequent to TCR engage-
ment may shape the unique EAE phenotype exhibited by
the MS2-3C8 Tg TCR.
Properties of individual TCR, the pattern of migration
of individual T cell clones, or the localization/abundance
of antigens are all likely to come into play, as was suggested
in the recent report of MOG Tg TCR mice. T cells spe-
cific for MOG35-55 gave rise to spontaneous optic neuri-
tis, most often in the absence of typical EAE symptoms
(37). Moreover, in each model of EAE the overwhelmingQuandt et al. 233
presentation of symptoms considered to be typical may
mask those symptoms occurring less frequently, such as
those described here. In this regard, TCR transgenic mice
may be valuable to glean antigen/MHC-specific pathology
from the otherwise heterogeneous presentation of disease
that is observed in other models. With respect to the simul-
taneous occurrence of cranial nerve deficits and the typical
sensorimotor signs, there is precedence in MS patients who
not uncommonly develop trigeminal neuralgia or more
rarely involvement of other cranial nerves.
Although it is difficult to extrapolate to human disease
clinical findings from experimental animal models, our re-
sults show that inflammatory responses of MS2-3C8 Tg T
cells directed against MBP 111–129 can induce unique
clinical and pathological features of damage to the nervous
system that are distinct from previously described Tg mod-
els (21) based on TCR recognizing different MBP peptide–
MHC complexes. Such correlations between specificity
and restriction of myelin-specific T cells may provide im-
portant insights into the immunopathological heterogene-
ity of MS. Clearly, humanized Tg mice expressing a single
TCR are biased and may not represent all clinical features
of the MS patient from whom the Tg TCR had been de-
rived. However, humanized TCR Tg mouse models could
be an exemplary way to dissect the phenotypic heterogene-
ity linked to a T cell response against defined myelin pep-
tides in the context of a disease-associated HLA-DR allele
in the development of MS.
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